In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...

In the phase 3 SUMMIT trial, tirzepatide, was found to reduce the risk for worsening heart failure in patients with preserved ...

I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial,” published in ...

An analysis of more than 5,300 patients with MS shows that access to early treatment in MS varies, though those with ...

The following is a summary of “Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A ...

Results from the GLORIOUS trial indicated that exenatide did not decrease mortality or severe organ injury among patients who ...

Identity theft in medical offices involves two major issues: fraudulent use of patient insurance information and unauthorized ...

Winter affects sleep schedules through daylight shifts, reduced sunlight, and seasonal illness, negatively impacting sleep ...

The following is a summary of “Characterization of changes in the resting-state intrinsic network in patients with diabetic ...

In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

The following is a summary of “Association between early anti-cytomegalovirus therapy and the incidence of chronic ...

The following is a summary of “ECMO Survivors’ Reflections on Their ICU Experience and Recovery,” published in the October ...